RG
AZN icon

Rathbones Group’s AstraZeneca AZN Stock Holding History

Rathbones Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56B Buy
8,054,943
+8,051,174
+213,616% +$1.55B 6.23% 1
2025
Q4 		$693K Sell
3,769
-2,100
-36% -$368K ﹤0.01% 408
2025
Q3 		$900K Hold
5,869
– – ﹤0.01% 362
2025
Q2 		$820K Sell
5,869
-127
-2% -$17.8K ﹤0.01% 361
2025
Q1 		$881K Hold
5,996
– – ﹤0.01% 340
2024
Q4 		$786K Sell
5,996
-856
-12% -$120K ﹤0.01% 358
2024
Q3 		$1.07M Buy
6,852
+113
+2% +$18.2K 0.01% 326
2024
Q2 		$1.05M Hold
6,739
– – 0.01% 325
2024
Q1 		$913K Hold
6,739
– – 0.01% 340
2023
Q4 		$908K Hold
6,739
– – 0.01% 327
2023
Q3 		$913K Buy
+6,739
New +$920K 0.01% 329

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Rathbones Group's AZN Position: Q1 2026 in Review

Rathbones Group increased its AstraZeneca (AZN) stake by 213,616% in Q1 2026, buying an estimated $1.55B and bringing the position to 8,054,943 shares worth $1.56B. The position accounts for 6.23% of the portfolio, ranked #1.

Rathbones Group first reported a position in AZN in Q3 2023 and has held it in 11 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Rathbones Group held 8,054,943 shares of AstraZeneca worth $1.56B as of Q1 2026.
  • Rathbones Group bought 8,051,174 AstraZeneca shares in Q1 2026, an estimated $1.55B.
  • AstraZeneca made up 6.23% of Rathbones Group's portfolio in Q1 2026, its #1 holding.
  • Rathbones Group first reported a position in AstraZeneca in Q3 2023 and has held it in 11 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Rathbones Group's 13F filing for Q1 2026, filed 12 May 2026.